Details for 2016800846

Up to date per 01.04.2026

Actions

Title / Product Name

DIAGNOSEVERFAHREN FÜR T-ZELL-THERAPIE

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2016800846

EP Publication Number

3302507

E-Number

1549073

Language

PCT Number

US16034885

Publication Date

11.04.2018 A

22.02.2023 B1

Registration Date

22.02.2023

AT Publication Date

15.03.2023

Application Date

27.05.2016

Registration Number

Priorities

28.05.2015

201562167738 P

02.12.2015

201562262111 P

IPC

A61K 35/17 20150101AFI20220729BHEP

Maximum Duration of Protection

27.05.2036

Owner

The United States of America, as represented by The Secretary, Department of Health and Human Services6701 Rockledge Drive, Suite 700, MSC 7788 Bethesda, MD 20892-7788US

Kite Pharma, Inc.2225 Colorado Avenue Santa Monica, CA 90404US

Representative

Torggler & Hofmann Patentanwälte GmbH & Co KGWilhelm-Greil-Straße 16/46020 InnsbruckAT

Inventor

BOT, Adrian2225 Colorado Avenue, Santa Monica, California 90404US

WIEZOREK, Jeffrey S.2225 Colorado Avenue, Santa Monica, California 90404US

GO, William2225 Colorado Avenue, Santa Monica, California 90404US

JAIN, Rajul2225 Colorado Avenue, Santa Monica, California 90404US

KOCHENDERFER, James N.Building 10-CRC, Room 3-3888 Bethesda, Maryland 20892US

ROSENBERG, Steven A.Building 10 - Hatfield CRC Room 3-3940 Bethesda, Maryland 20892US

Information about Fees